...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Upcoming CVOT results
2
Apr 12, 2019 10:08AM
2
Apr 12, 2019 10:17AM
2
Apr 12, 2019 10:44AM
3
Apr 12, 2019 10:53AM

Bear was this achieved with very high absolute risk patients or lower risk patients?

"Amarin's REDUCE-IT achieved a very significant 26% RRR for 3-point MACE composite secondary outcome and very significant 25% RRR for 5-point MACE primary outcome. Additionally, REDUCE-IT achieved a significant 20% RRR (p=0.03) in cardiovascular death."

 

Koo

 

 

3
Apr 12, 2019 11:14AM
5
Apr 12, 2019 11:41AM
1
Apr 12, 2019 12:02PM
2
Apr 12, 2019 12:06PM
4
Apr 14, 2019 10:11PM

Apr 15, 2019 12:01AM
6
Apr 15, 2019 08:14AM
Share
New Message
Please login to post a reply